SKF 77434 hydrobromide
SKF 77434 hydrobromide structure
|
Common Name | SKF 77434 hydrobromide | ||
|---|---|---|---|---|
| CAS Number | 300561-58-4 | Molecular Weight | 376.29 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C19H22BrNO2 | Melting Point | N/A | |
| MSDS | USA | Flash Point | N/A | |
Use of SKF 77434 hydrobromideSKF 77434 hydrobromide is a selective dopamine D1 receptor partial agonist. SKF 77434 hydrobromide has the potential to study cocaine addiction[1]. |
| Name | 5-phenyl-3-prop-2-enyl-1,2,4,5-tetrahydro-3-benzazepine-7,8-diol,hydrobromide |
|---|---|
| Synonym | More Synonyms |
| Description | SKF 77434 hydrobromide is a selective dopamine D1 receptor partial agonist. SKF 77434 hydrobromide has the potential to study cocaine addiction[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C19H22BrNO2 |
|---|---|
| Molecular Weight | 376.29 |
| Exact Mass | 375.08300 |
| PSA | 43.70000 |
| LogP | 4.16980 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
|
Dopamine-dependent desensitization of dopaminergic signaling in the developing mouse striatum.
J. Neurosci. 22(22) , 9841-9, (2002) The dynamics of dopamine receptor signaling efficacy were characterized in developing mice by measuring striatal c-Fos expression after dopaminergic agonist treatment at postnatal day 4 (P4) to P18. C... |
|
|
Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway.
Proc. Natl. Acad. Sci. U. S. A. 96(9) , 5280-5, (1999) To study the physiological and molecular mechanisms of age-related memory loss, we assessed spatial memory in C57BL/B6 mice from different age cohorts and then measured in vitro the late phase of hipp... |
|
|
Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
J. Pharmacol. Exp. Ther. 262(2) , 855-65, (1992) Administration of the selective D1-dopamine receptor agonist 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine (SKF-38393) to neonatal 6-hydroxydopamine-lesioned rats results in profound beha... |
| (+/-)-7,8-Dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrobromide |
| Atrial natriuretic factor (1-28) (human,porcine) |